ensitrelvir: Clinical Trials

3 trials of ensitrelvir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1

Follow ensitrelvir: new trials by email Literature Review of ensitrelvir trials Research Report on ensitrelvir

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
S-217622, Placebo - SARS-CoV-2 Infection
Phase 3CompletedShionogi37012023-06-092026-10-07
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Shionogi Protease Inhibitor (S-217622), placebo - COVID-19
Phase 3TerminatedUniversity of Minnesota6022022-12-232026-09-24
A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19
S-217622, Placebo - SARS-CoV-2 Infection
Phase 3CompletedShionogi20932022-08-032026-11-17

Conditions studied

COVID-19 (3)

Sponsors

Shionogi (2)  ·  University of Minnesota (1)

Countries

Argentina (3)  ·  Japan (3)  ·  South Africa (3)  ·  United States (3)  ·  Brazil (2)  ·  Mexico (2)  ·  Peru (2)  ·  Poland (2)  ·  Thailand (2)  ·  Uganda (2)  ·  Australia (1)  ·  Colombia (1)  ·  Denmark (1)  ·  Georgia (1)  ·  Germany (1)

Top investigators

Cavan Reilly, PhD (1)  ·  Jason Baker, MD (1)

Results publications

PMID 39960062, PMID 41672106, PMID 42127390

NIH funding

2023 (1)